Summary
This 8-K filing from Gilead Sciences, Inc. (GILD), dated January 31, 2006, primarily details executive compensation decisions made by the Compensation Committee on January 25, 2006. Investors will be interested in the awarded 2005 bonuses and the approved 2006 base salaries for named executive officers, which reflect performance and market competitiveness. The filing also introduces a new Corporate Bonus Plan effective January 1, 2006, designed to link compensation directly to company and individual performance, with clear objectives outlined for 2006. This plan aims to motivate and retain key talent by offering bonus opportunities tied to specific metrics across various business functions.
Key Highlights
- 1Gilead Sciences' Compensation Committee approved 2005 bonuses for named executive officers on January 25, 2006, based on company and individual performance targets.
- 22006 base salaries for named executive officers were also approved, with adjustments for key roles such as CEO, CFO, and EVP of R&D.
- 3A new Corporate Bonus Plan was adopted, effective January 1, 2006, to align employee compensation with corporate and individual performance.
- 4The bonus plan allows for actual awards ranging from 0% to 150% of the target bonus, which is expressed as a percentage of base salary.
- 5Company performance criteria for 2006 bonuses include commercial growth, product development, administration, research, manufacturing, financial performance, corporate development, and government affairs.
- 6The CEO's 2006 bonus will be 100% based on company performance, while other named executive officers will have a 75% company performance and 25% individual performance weighting.
- 7Eligibility for the bonus plan excludes employees hired after October 31st of the performance year or those who terminate employment before the payment date.